{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:20:50Z","timestamp":1790774450960,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd008347.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000}}],"reference-count":122,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008347.pub4","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T15:06:13Z","timestamp":1657292773000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Local intramuscular transplantation of autologous bone marrow mononuclear cells for critical lower limb ischaemia"],"prefix":"10.1002","volume":"2022","author":[{"given":"Bobak","family":"Moazzami","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Lipids, Department of Medicine; Emory University School of Medicine; Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinat","family":"Mohammadpour","sequence":"additional","affiliation":[{"name":"Adelaide Medical School; Faculty of Health and Medical Sciences, University of Adelaide; Adelaide Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohyra E","family":"Zabala","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Lipids, Department of Medicine; Emory University School of Medicine; Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermia","family":"Farokhi","sequence":"additional","affiliation":[{"name":"Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA); Universal Scientific Education and Research Network (USERN); Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aria","family":"Roohi","sequence":"additional","affiliation":[{"name":"Division of Angiology and Hemostasis; Geneva University Hospitals and Faculty of Medicine; Geneva Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Dolmatova","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine; Emory University School of Medicine; Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasra","family":"Moazzami","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine; Emory University School of Medicine; Atlanta Georgia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD008347.pub4-BIB0001|cit1","first-page":"155","article-title":"Bone-marrow cells in therapy of critical limb ischaemia of lower extremities - own experience","volume":"12","author":"Barc","year":"2006","journal-title":"Acta Angiologica"},{"issue":"5","key":"10.1002\/14651858.CD008347.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.6002\/ect.2012.0129","article-title":"Autologous bone marrow mononuclear cells transplant in patients with critical leg ischemia: preliminary clinical results","volume":"11","author":"Li","year":"2013","journal-title":"Experimental and Clinical Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD008347.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/SLA.0000000000002896","article-title":"No clinical benefit of intramuscular delivery of bone marrow-derived mononuclear cells in non-reconstructable peripheral arterial disease: results of a phase-III randomized-controlled trial","volume":"268","author":"Lindeman","year":"2018","journal-title":"Annals of Surgery"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0004|cit4","unstructured":"Bone marrow auto graft in limb ischemia (BALI) clinicaltrials.gov\/ct2\/show\/study\/NCT00904501"},{"issue":"11","key":"10.1002\/14651858.CD008347.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1253\/circj.CJ-17-0045","article-title":"Autologous bone marrow mononuclear cell implantation and its impact on the outcome of patients with critical limb ischemia - results of a randomized, double-blind, placebo-controlled trial","volume":"81","author":"Pignon","year":"2017","journal-title":"Circulation Journal"},{"issue":"1","key":"10.1002\/14651858.CD008347.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-9-165","article-title":"The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design","volume":"9","author":"Benoit","year":"2011","journal-title":"Journal of Translational Medicine"},{"issue":"4","key":"10.1002\/14651858.CD008347.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1024\/0301-1526.37.4.319","article-title":"Design and rationale of a randomized, double-blind, placebo-controlled phase III study for autologous bone marrow cell transplantation in critical limb ischemia: the bone marrow outcomes trial in critical limb ischemia (BONMOT-CLI)","volume":"37","author":"Amann","year":"2008","journal-title":"Vasa"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008347.pub4-BIB0008|cit8","first-page":"144","article-title":"Induction of arteriogenesis by autologous bone marrow transplantation (aBMT) in critical limb ischemia (CLI): the BONMOT 1 and 2 (bone marrow transplantation) studies","volume":"29","author":"Luedemann","year":"2008","journal-title":"European Heart Journal"},{"issue":"1","key":"10.1002\/14651858.CD008347.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"111\u20136","DOI":"10.1038\/bmt.2009.102","article-title":"Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia","volume":"45","author":"Burt","year":"2010","journal-title":"Bone Marrow Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD008347.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1423-0410.2008.01138.x","article-title":"Characterization and comparison of bone marrow and peripheral blood mononuclear cells used for cellular therapy in critical leg ischaemia: towards a new cellular product","volume":"96","author":"Capiod","year":"2009","journal-title":"Vox Sanguinis"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0011|cit11","first-page":"6227","article-title":"Autologous bone marrow mesenchymal stem cell transplantation for treatment of diabetic foot following amplification in vitro","volume":"13","author":"Chen","year":"2009","journal-title":"Journal of Clinical Rehabilitative Tissue Engineering Research"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1000-1948(08)60031-3","article-title":"Autologous transplantation of bone marrow mesenchymal stem cells on diabetic patients with lower limb ischemia","volume":"23","author":"Debin","year":"2008","journal-title":"Journal of Medical Colleges of PLA"},{"issue":"2","key":"10.1002\/14651858.CD008347.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jvs.2013.01.037","article-title":"Transplantation of purified CD34+ cells in the treatment of critical limb ischemia","volume":"58","author":"Dong","year":"2013","journal-title":"Journal of Vascular Surgery"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ebiom.2018.08.038","article-title":"Purified CD34(+) cells versus peripheral blood mononuclear cells in the treatment of angiitis-induced no-option critical limb ischaemia: 12-month results of a prospective randomised single-blinded non-inferiority trial","volume":"35","author":"Dong","year":"2018","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1002\/14651858.CD008347.pub4-BIB0015|cit15","first-page":"82\u20136","article-title":"Umbilical cord mesenchymal stem cells combined with bone marrow stem cells for treatment of lower limb ischemia","volume":"21","author":"Du","year":"2017","journal-title":"Chinese Journal of Tissue Engineering Research"},{"issue":"3","key":"10.1002\/14651858.CD008347.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"816\u201325","DOI":"10.1016\/j.ymthe.2016.12.019","article-title":"Phase Ib safety, two-dose study of MultiGeneAngio in patients with chronic critical limb ischemia","volume":"25","author":"Flugelman","year":"2017","journal-title":"Molecular Therapy"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD008347.pub4-BIB0017|cit17","first-page":"88","article-title":"Adult stem\/progenitor cells derived from peripheral blood as a personalized treatment for critical limb ischemia (CLI)","volume":"25","author":"Frogel","year":"2017","journal-title":"Vascular"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1479-5876-11-143","article-title":"A double blind randomized placebo controlled phase I\/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia","volume":"11","author":"Gupta","year":"2013","journal-title":"Journal of Translational Medicine"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0019|cit19","unstructured":"Gurunathan Mani S Raju R Kuppu Sampath V The Vascular Society of Great Britain and Ireland Yearbook 2009: Multicentre randomised clinical trial on the role of autologous bone-marrow aspirate-concentrate (BMAC)\/CD34\/(EPC) in non-reconstructable critically ischaemic limbs www.vascularsociety.org.uk\/_userfiles\/pages\/files\/Document%20Library\/yearbook_09_web_no_members.pdf"},{"issue":"1","key":"10.1002\/14651858.CD008347.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/FJC.0b013e3181c37da4","article-title":"Sarpogrelate hydrochloride, a selective 5-hydroxytryptamine 2A antagonist, augments autologous bone marrow mononuclear cell implantation-induced improvement in endothelium-dependent vasodilation in patients with critical limb ischemia","volume":"55","author":"Higashi","year":"2010","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"3","key":"10.1002\/14651858.CD008347.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0950-821X(05)80155-0","article-title":"Treatment of non-healing skin ulcers with autologous activated mononuclear cells","volume":"8","author":"Holzinger","year":"1994","journal-title":"European Journal of Vascular Surgery"},{"issue":"8","key":"10.1002\/14651858.CD008347.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1253\/circj.CJ-17-1220","article-title":"Outcome from a randomized controlled clinical trial - improvement of peripheral arterial disease by granulocyte colony-stimulating factor-mobilized autologous peripheral-blood-mononuclear cell transplantation (IMPACT)","volume":"82","author":"Horie","year":"2018","journal-title":"Circulation Journal"},{"issue":"9","key":"10.1002\/14651858.CD008347.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2337\/diacare.28.9.2155","article-title":"Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes","volume":"28","author":"Huang","year":"2005","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1002\/14651858.CD008347.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.jvs.2011.06.118","article-title":"Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia","volume":"54","author":"Iafrati","year":"2011","journal-title":"Journal of Vascular Surgery"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jvs.2010.06.135","article-title":"Bone marrow aspirate concentrate in critical limb ischemia: results of a multicenter randomized double-blind trial","volume":"52","author":"Iafrati","year":"2010","journal-title":"Journal of Vascular Surgery"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD008347.pub4-BIB0026|cit26","first-page":"47S","article-title":"Bone marrow aspirate concentrate in critical limb ischemia: results of an abridged prospective randomized pivotal trial in no option CLI","volume":"63","author":"Iafrati","year":"2016","journal-title":"Abstracts of the 2016 Vascular Annual Meeting, The Society for Vascular Surgery"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"130b","DOI":"10.1182\/blood.V104.11.4174.4174","article-title":"Autologous peripheral blood stem cell implantation as therapeutic angiogenesis for severe limb ischemia","volume":"104","author":"Han","year":"2004","journal-title":"Blood"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0028|cit28","unstructured":"Intra-arterial stem cell therapy for patients with chronic limb ischemia (CLI) (JUVENTAS) clinicaltrials.gov\/ct2\/show\/NCT00371371"},{"issue":"6","key":"10.1002\/14651858.CD008347.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jvs.2010.02.020","article-title":"Rationale and design of the JUVENTAS trial for repeated intra-arterial infusion of autologous bone marrow-derived mononuclear cells in patients with critical limb ischemia","volume":"51","author":"Sprengers","year":"2010","journal-title":"Journal of Vascular Surgery"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0030|cit30","first-page":"80","article-title":"Autologous tissue repair cells (TRC) in the treatment of ischemia induced chronic tissue ulcers of diabetic foot patients without option of revascularisation: first year experiences","volume":"102","author":"Kirana","year":"2007","journal-title":"Medizinische Klinik"},{"issue":"4","key":"10.1002\/14651858.CD008347.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1742-1241.2011.02886.x","article-title":"Autologous stem cell therapy in the treatment of limb ischaemia induced chronic tissue ulcers of diabetic foot patients","volume":"66","author":"Kirana","year":"2012","journal-title":"International Journal of Clinical Practice"},{"issue":"9","key":"10.1002\/14651858.CD008347.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3727\/096368912X636948","article-title":"No difference in intra-arterial and intramuscular delivery of autologous bone marrow cells in patients with advanced critical limb ischemia","volume":"21","author":"Klepanec","year":"2012","journal-title":"Cell Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD008347.pub4-BIB0033|cit33","first-page":"28","article-title":"Use of autologous progenitor cells of the bone marrow in treatment of patients with lower-limb atherosclerosis obliterans","volume":"15","author":"Korymasov","year":"2009","journal-title":"Angiologiia iSosudistaia Khirurgiia"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"E2020","DOI":"10.1016\/S0735-1097(11)62020-2","article-title":"Therapeutic angiogenesis in patients with severe limb ischemia by transplantation of an autologous bone marrow-derived combination stem cell product","volume":"57","author":"Lasala","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD008347.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.diabres.2010.12.010","article-title":"Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial","volume":"92","author":"Lu","year":"2011","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"14 Suppl 1","key":"10.1002\/14651858.CD008347.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"E1473","DOI":"10.1016\/S0735-1097(11)61473-3","article-title":"Autologous bone marrow cells transplantation in patients with advanced critical limb ischemia: no difference in intra-arterial and intramuscular application","volume":"57","author":"Madaric","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"B150","DOI":"10.1016\/j.jacc.2011.10.569","article-title":"Higher CD34+ cells concentration and lower degree of inflammation are associated with better therapeutic response to autologous bone marrow cells application in patients with critical limb ischemia","volume":"58","author":"Madaric","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.jcyt.2015.03.601","article-title":"A first of its kind phase II clinical trial in critical limb ischemia patients using bone marrow derived, pooled, allogeneic mesenchymal stromal cells (Stempeucel)","volume":"17","author":"Majumdar","year":"2015","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1002\/14651858.CD008347.pub4-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jcyt.2020.02.007","article-title":"Autologous bone marrow mesenchymal stromal cell therapy for \"no-option\" critical limb ischemia is limited by karyotype abnormalities","volume":"22","author":"Mohamed","year":"2020","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1002\/14651858.CD008347.pub4-BIB0040|cit40","first-page":"388","article-title":"Safety and efficacy of repeated bone marrow mononuclear cell therapy in patients with critical limb ischemia in a pilot randomized controlled trial","volume":"19","author":"Molavi","year":"2016","journal-title":"Archives of Iranian Medicine"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD008347.pub4-BIB0041|cit41","first-page":"131S\u20132S","article-title":"Intramuscular injection of autologous bone marrow cells to prevent amputation in critical limb ischemia: the results of the phase III MOBILE trial","volume":"65","author":"Murphy","year":"2017","journal-title":"Abstracts of the 2017 Vascular Annual Meeting"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0042|cit42","unstructured":"Safety and feasibility study of autologous bone marrow cell transplantation in patients with PAOD clinicaltrials.gov\/ct\/show\/NCT00282646"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0043|cit43","unstructured":"Autologous bone marrow cell treatment in peripheral atherosclerosis clinicaltrials.gov\/ct2\/show\/NCT00306085"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0044|cit44","unstructured":"Study of autologous bone marrow concentrate for the treatment of CLI clinicaltrials.gov\/ct2\/show\/NCT00498069"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0045|cit45","unstructured":"Autologous bone marrow-derived mononuclear cells for therapeutic arteriogenesis in patients with limb ischemia (ABC) clinicaltrials.gov\/ct2\/show\/NCT00539266"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0046|cit46","unstructured":"Feasability study of autologous bone marrow aspirate concentrate for treatment of CLI clinicaltrials.gov\/ct2\/show\/NCT00595257"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0047|cit47","unstructured":"Injection of autologous CD34-positive cells for critical limb ischemia (ACT34-CLI) clinicaltrials.gov\/ct2\/show\/NCT00616980"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0048|cit48","unstructured":"Safety study of adult stem cells to treat patients with severe leg artery disease (SCRIPT-CLI) clinicaltrials.gov\/ct2\/show\/NCT00913900"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0049|cit49","unstructured":"A clinical trial on diabetic foot using peripheral blood derived stem cells for treating critical limb ischemia clinicaltrials.gov\/ct2\/show\/NCT00922389"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0050|cit50","unstructured":"Comparison of autologous mesenchymal stem cells and mononuclear cells on diabetic critical limb ischemia and foot ulcer clinicaltrials.gov\/ct2\/show\/NCT00955669"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0051|cit51","unstructured":"Safety and efficacy study of autologous concentrated bone marrow aspirate (cBMA) for critical limb ischemia (CLI) clinicaltrials.gov\/ct2\/show\/NCT01049919"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0052|cit52","unstructured":"Bone marrow aspirate concentrate (BMAC) for treatment of critical limb ischemia (CLI) clinicaltrials.gov\/ct2\/show\/NCT01245335"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0053|cit53","unstructured":"Autologous angiogenic cell precursors (ACPs) for the treatment of peripheral artery disease clinicaltrials.gov\/ct2\/show\/NCT01584986"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0054|cit54","unstructured":"Cell therapy with mesenchymal stem cell in ischemic limb disease clinicaltrials.gov\/ct2\/show\/NCT02336646"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0055|cit55","unstructured":"The efficacy and safety of Rexmyelocel-T to treat ischemic ulcers in subjects with CLI Rutherford category 5 and DM clinicaltrials.gov\/ct2\/show\/NCT03174522"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0056|cit56","unstructured":"Autologous BMMNC combined with HA therapy for PAOD clinicaltrials.gov\/ct2\/show\/NCT03214887"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0057|cit57","unstructured":"Granulocyte-macrophage stimulating factor (GM-CSF) in peripheral arterial disease clinicaltrials.gov\/ct2\/show\/NCT03304821"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0058|cit58","unstructured":"Allogeneic ABCB5-positive stem cells for treatment of PAOD clinicaltrials.gov\/ct2\/show\/NCT03339973"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0059|cit59","first-page":"S31","article-title":"Adult stem\/progenitor cells as a personalised treatment for peripheral vascular disease","volume":"60","author":"Niven","year":"2017","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"iii309","DOI":"10.1093\/ndt\/gfx152.SP534","article-title":"Effect of autologous G-CSF-mobilized CD34+ cell transplantation in hemodialysis patients with critical limb ischemia","volume":"Suppl 3","author":"Ohtake","year":"2017","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0061|cit61","unstructured":"Pawan K Anoop CH Seetharam RN Das AK Majumdar AS Pherwani A A randomized, double blind, placebo controlled, single dose, phase I\/II study using adult bone marrow derived allogeneic mesenchymal stem cells in patients with critical limb ischemia XXVI Annual Meeting of the European Society for Vascular Surgery; 2012 Sep 19-21; Bologna, Italy 2012 154"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0062|cit62","unstructured":"ALDHbr cells for critical limb ischemia, randomized trial (CLI-001) clinicaltrials.gov\/ct2\/show\/NCT00392509"},{"issue":"7","key":"10.1002\/14651858.CD008347.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/ccd.23066","article-title":"A randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia","volume":"78","author":"Perin","year":"2011","journal-title":"Catheterization and Cardiovascular Interventions"},{"issue":"5","key":"10.1002\/14651858.CD008347.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"667\u201373","DOI":"10.1016\/j.ahj.2014.07.021","article-title":"Rationale and design for PACE: patients with intermittent claudication injected with ALDH bright cells","volume":"168","author":"Perin","year":"2014","journal-title":"American Heart Journal"},{"issue":"15","key":"10.1002\/14651858.CD008347.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1417\u201328","DOI":"10.1161\/CIRCULATIONAHA.116.025707","article-title":"Evaluation of cell therapy on exercise performance and limb perfusion in peripheral artery disease: the CCTRN PACE Trial (patients with intermittent claudication injected with ALDH bright cells)","volume":"135","author":"Perin","year":"2017","journal-title":"Circulation"},{"issue":"24","key":"10.1002\/14651858.CD008347.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"2631\u20139","DOI":"10.1001\/jama.2013.282540","article-title":"Effect of progenitor cell mobilization with granulocyte-macrophage colony-stimulating factor in patients with peripheral artery disease: a randomized clinical trial","volume":"310","author":"Poole","year":"2013","journal-title":"JAMA"},{"issue":"11","key":"10.1002\/14651858.CD008347.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3727\/096368910X514170","article-title":"Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer","volume":"19","author":"Prochazka","year":"2010","journal-title":"Cell Transplantation"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0068|cit68","first-page":"37","article-title":"Intra-arterial administration of bone marrow mononuclear cells in patients with critical limb ischemia - a randomized-start, placebo-controlled pilot trial (PROVASA)","volume":"39","author":"Walter","year":"2010","journal-title":"Vasa"},{"issue":"1","key":"10.1002\/14651858.CD008347.pub4-BIB0069|cit69","first-page":"26","article-title":"Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA)","volume":"4","author":"Walter","year":"2011","journal-title":"Circulation: Cardiovascular Interventions"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0070|cit70","unstructured":"Use of vascular repair cells (VRC) in patients with peripheral arterial disease to treat critical limb ischemia (RESTORE-CLI) clinicaltrials.gov\/ct2\/show\/NCT00468000"},{"issue":"6","key":"10.1002\/14651858.CD008347.pub4-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/mt.2012.52","article-title":"Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trial","volume":"20","author":"Powell","year":"2012","journal-title":"Molecular Therapy: the Journal of the American Society of Gene Therapy"},{"issue":"4","key":"10.1002\/14651858.CD008347.pub4-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jvs.2011.04.006","article-title":"Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia","volume":"54","author":"Powell","year":"2011","journal-title":"Journal of Vascular Surgery"},{"issue":"2","key":"10.1002\/14651858.CD008347.pub4-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jvir.2020.09.003","article-title":"Randomized, double-blind, placebo-controlled trial to evaluate safety and therapeutic efficacy of angiogenesis induced by intraarterial autologous bone marrow\u2013derived stem cells in patients with severe peripheral arterial disease","volume":"32","author":"Sharma","year":"2021","journal-title":"Journal of Vascular and Interventional Radiology"},{"issue":"2","key":"10.1002\/14651858.CD008347.pub4-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5114\/aoms.2013.39935","article-title":"Combined autologous bone marrow mononuclear cell and gene therapy as the last resort for patients with critical limb ischemia","volume":"11","author":"Sk\u00f3ra","year":"2015","journal-title":"Archives of Medical Science"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0075|cit75","unstructured":"Subramaniyam V Reddy U Harris W Sutcliffe D Safety and efficacy of bone marrow mobilization with granulocyte-macrophage colony stimulating factor in patients with intermittent claudication American College of Cardiology 55th Annual Scientific Session; 2006 Mar 11\u201314; Atlanta, GA 2006"},{"issue":"1","key":"10.1002\/14651858.CD008347.pub4-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ahj.2009.04.014","article-title":"Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral arterial disease","volume":"158","author":"Subramaniyam","year":"2009","journal-title":"American Heart Journal"},{"issue":"10","key":"10.1002\/14651858.CD008347.pub4-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jcyt.2013.05.017","article-title":"Peripheral blood-derived autologous stem cell therapy for the treatment of patients with late-stage peripheral artery disease - results of the short- and long-term follow-up","volume":"15","author":"Szabo","year":"2013","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1002\/14651858.CD008347.pub4-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1564\u20138","DOI":"10.1016\/j.jvs.2010.02.020","article-title":"Rationale and design of the JUVENTAS trial for repeated intra arterial infusion of autologous bone marrow-derived mononuclear cells in patients with critical limb ischemia","volume":"51","author":"Sprengers","year":"2010","journal-title":"Journal of Vascular Surgery"},{"issue":"10","key":"10.1002\/14651858.CD008347.pub4-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.114.012913","article-title":"Effect of repetitive intra-arterial infusion of bone marrow mononuclear cells in patients with no-option limb ischemia: the randomized, double-blind, placebo-controlled rejuvenating endothelial progenitor cells via transcutaneous intra-arterial supplementation (JUVENTAS) trial","volume":"131","author":"Teraa","year":"2015","journal-title":"Circulation"},{"issue":"11","key":"10.1002\/14651858.CD008347.pub4-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"2692\u2013701","DOI":"10.1111\/trf.13203","article-title":"Critical limb ischemia: thrombogenic evaluation of two autologous cell therapy products and biologic profile in treated patients","volume":"55","author":"Tournois","year":"2015","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0081|cit81","first-page":"37","article-title":"Intra-arterial administration of bone marrow mononuclear cells in patients with critical limb ischemia - a randomized-start, placebo-controlled pilot trial (PROVASA)","volume":"39","author":"Walter","year":"2010","journal-title":"Vasa"},{"issue":"1","key":"10.1002\/14651858.CD008347.pub4-BIB0082|cit82","first-page":"26","article-title":"Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia a randomized-start, placebo-controlled pilot trial (PROVASA)","volume":"4","author":"Walter","year":"2011","journal-title":"Circulation: Cardiovascular Interventions"},{"issue":"6","key":"10.1002\/14651858.CD008347.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1501\u201312","DOI":"10.1016\/j.avsg.2014.03.002","article-title":"Combination of autologous transplantation of G-CSF mobilized peripheral blood mononuclear cells and Panaxnotoginseng saponins in the treatment of unreconstructable critical limb ischemia","volume":"28","author":"Wang","year":"2014","journal-title":"Annals of Vascular Surgery"},{"issue":"6","key":"10.1002\/14651858.CD008347.pub4-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"113S","DOI":"10.1016\/j.jvs.2017.03.210","article-title":"Ethnic minorities with critical limb ischemia derive equal amputation risk reduction from autologous cell therapy compared to Caucasians","volume":"65","author":"Wang","year":"2017","journal-title":"Journal of Vascular Surgery"},{"issue":"6","key":"10.1002\/14651858.CD008347.pub4-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1850\u20137.e2","DOI":"10.1016\/j.jvs.2017.01.054","article-title":"Rationale and design of the MarrowStim PAD Kit for the treatment of critical limb ischemia in subjects with severe peripheral arterial disease (MOBILE) trial investigating autologous bone marrow cell therapy for critical limb ischemia","volume":"65","author":"Wang","year":"2017","journal-title":"Journal of Vascular Surgery"},{"issue":"1","key":"10.1002\/14651858.CD008347.pub4-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"176\u201381.e1","DOI":"10.1016\/j.jvs.2017.09.057","article-title":"Rationale and design of the clinical and histologic analysis of mesenchymal stromal cells in amPutations (CHAMP) trial investigating the therapeutic mechanism of mesenchymal stromal cells in the treatment of critical limb ischemia","volume":"68","author":"Wang","year":"2018","journal-title":"Journal of Vascular Surgery"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0087|cit87","unstructured":"Allogeneic mesenchymal stromal cells for angiogenesis and neovascularization in no-option ischemic limbs (SAIL) clinicaltrials.gov\/ct2\/show\/NCT03042572"},{"issue":"2","key":"10.1002\/14651858.CD008347.pub4-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jvs.2017.09.026","article-title":"Rationale and design of the SAIL trial for intramuscular injection of allogeneic mesenchymal stromal cells in no-option critical limb ischemia","volume":"67","author":"Wijnand","year":"2018","journal-title":"Journal of Vascular Surgery"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3109\/14653240903518163","article-title":"Safety and efficacy of granulocyte colony-stimulating factor administration following autologous intramuscular implantation of bone marrow mononuclear cells: a randomized controlled trial in patients with advanced lower limb ischemia","volume":"12","author":"Zafarghandi","year":"2010","journal-title":"Cytotherapy"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0090|cit90","first-page":"6040","article-title":"Endovascular transplantation of autologous bone marrow stem cells for the treatment of diabetic lower limb arterial occlusion","volume":"14","author":"Zhang","year":"2010","journal-title":"Journal of Clinical Rehabilitative Tissue Engineering Research"},{"issue":"8","key":"10.1002\/14651858.CD008347.pub4-BIB0091|cit91","first-page":"1464","article-title":"Combined transplantation of autologous peripheral blood and bone narrow stem cells for the treatment of diabetic lower limb ischaemia: randomized controlled trial","volume":"12","author":"Zhao","year":"2008","journal-title":"Journal of Clinical Rehabilitative Tissue Engineering Research"},{"issue":"5","key":"10.1002\/14651858.CD008347.pub4-BIB0092|cit92","first-page":"5177\u201385","article-title":"Efficacy, safety and influencing factors of intra-calf muscular injection of bone marrow mononuclear cells in the treatment of type 2 diabetes mellitus-induced lower extremity vascular disease","volume":"14","author":"Zhou","year":"2017","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"13","key":"10.1002\/14651858.CD008347.pub4-BIB0093|cit93","first-page":"1998\u20132002","article-title":"Autologous CD34+ cell transplantation promotes angiogenesis in older adult patients with atherosclerotic ischemia: study protocol for a prospective, single-center, open label, randomized controlled clinical trial","volume":"21","author":"Zhou","year":"2017","journal-title":"Chinese Journal of Tissue Engineering Research"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0094|cit94","unstructured":"Autologous bone marrow for lower extremity ischemia treating clinicaltrials.gov\/ct2\/show\/study\/NCT00753025"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0095|cit95","unstructured":"Safety and efficacy study of autologous BM-MNC processed by two methods for treating patients with chronic limb ischemia clinicaltrials.gov\/ct2\/show\/study\/NCT01446055"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0096|cit96","unstructured":"Monocentric trial: stem cell emergency life threatening limbs arteriopathy (SCELTA) clinicaltrials.gov\/ct2\/show\/NCT02454231"},{"issue":"8","key":"10.1002\/14651858.CD008347.pub4-BIB0097|cit97","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010747.pub2","article-title":"Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients","author":"Abdul Wahid","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD008347.pub4-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jvs.2009.07.113","article-title":"Use of autologous bone marrow mononuclear cell implantation therapy as a limb salvage procedure in patients with severe peripheral arterial disease","volume":"50","author":"Franz","year":"2009","journal-title":"Journal of Vascular Surgery"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"GRADE Working Group","year":"2004","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0100|cit100","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime)"},{"issue":"10","key":"10.1002\/14651858.CD008347.pub4-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1161\/01.CIR.0000121427.53291.78","article-title":"Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia","volume":"109","author":"Higashi","year":"2004","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0102|cit102","unstructured":"Higgins JT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0103|cit103","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017 Available from training.cochrane.org\/handbook\/archive\/v5.2"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0104|cit104","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Welch VA Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook\/archive\/v6.2"},{"issue":"11","key":"10.1002\/14651858.CD008347.pub4-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1161\/CIRCULATIONAHA.106.174526","article-title":"ACC\/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery\/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and theACC\/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation","volume":"113","author":"Hirsch","year":"2006","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD008347.pub4-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1160\/TH03-06-0343","article-title":"Autologous transplantation of peripheral blood stem cells as effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities","volume":"91","author":"Huang","year":"2004","journal-title":"Thrombosis and Haemostasis"},{"issue":"9","key":"10.1002\/14651858.CD008347.pub4-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2337\/diacare.28.9.2155","article-title":"Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes","volume":"28","author":"Huang","year":"2005","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1002\/14651858.CD008347.pub4-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.atherosclerosis.2009.08.028","article-title":"Impact of implanted bone marrow progenitor cell composition on limb salvage after cell implantation in patients with critical limb ischemia","volume":"209","author":"Iso","year":"2010","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1002\/14651858.CD008347.pub4-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.avsg.2009.10.012","article-title":"Safety and efficacy of therapeutic angiogenesis as a novel treatment in patients with critical limb ischemia","volume":"24","author":"Lara-Hernandez","year":"2010","journal-title":"Annals of Vascular Surgery"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0110|cit110","unstructured":"Lefebvre C Glanville J Briscoe S Littlewood A Marshall C Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook\/archive\/v6.2"},{"issue":"23","key":"10.1002\/14651858.CD008347.pub4-BIB0111|cit111","first-page":"4296\u2013300","article-title":"Autologous bone marrow stem cell transplantation in critical limb ischemia: a meta-analysis of randomized controlled trials","volume":"125","author":"Liu","year":"2012","journal-title":"Chinese Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD008347.pub4-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"e0125032","DOI":"10.1371\/journal.pone.0125032","article-title":"Therapeutic efficacy of stem cell-based therapy in peripheral arterial disease: a meta-analysis","volume":"10","author":"Liu","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0113|cit113","first-page":"5\u201367","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"45 Suppl 1","author":"Norgren","year":"2007","journal-title":"Journal of Vascular Surgery"},{"issue":"8","key":"10.1002\/14651858.CD008347.pub4-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/CIRCRESAHA.116.309045","article-title":"Autologous cell therapy for peripheral arterial disease: systematic review and meta-analysis of randomized, non-randomized, and non-controlled studies","volume":"120","author":"Rigato","year":"2017","journal-title":"Circulation Research"},{"key":"10.1002\/14651858.CD008347.pub4-BIB0115|cit115","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook\/archive\/v6.2"},{"issue":"6","key":"10.1002\/14651858.CD008347.pub4-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"897\u2013903","DOI":"10.1161\/01.CIR.103.6.897","article-title":"Augmentation of postnatal neovascularization with autologous bone marrow transplantation","volume":"103","author":"Shintani","year":"2001","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD008347.pub4-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"H886","DOI":"10.1152\/ajpheart.00142.2006","article-title":"Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury","volume":"291","author":"Takahashi","year":"2006","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"9331","key":"10.1002\/14651858.CD008347.pub4-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(02)09670-8","article-title":"Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation of bone-marrow cells: a pilot study and a randomized controlled trial","volume":"360","author":"Tateishi-Yuyama","year":"2002","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD008347.pub4-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SLA.0b013e3182854cf1","article-title":"Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta analysis of randomized controlled clinical trials","volume":"258","author":"Teraa","year":"2013","journal-title":"Annals of Surgery"},{"issue":"12","key":"10.1002\/14651858.CD008347.pub4-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1517\/14712598.2011.626401","article-title":"Autologous bone marrow cell therapy for patients with peripheral arterial disease: a meta analysis of randomized controlled trials","volume":"11","author":"Wen","year":"2011","journal-title":"Expert Opinion on Biological Therapy"},{"issue":"12","key":"10.1002\/14651858.CD008347.pub4-BIB0121|cit121","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008347.pub2","article-title":"Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia","author":"Moazzami","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD008347.pub4-BIB0122|cit122","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008347.pub3","article-title":"Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia","author":"Moazzami","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T21:29:30Z","timestamp":1704230970000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008347.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Vascular Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":122,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008347.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]}}}